Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy

被引:21
作者
Jones, Christine E. [1 ]
Munoz, Flor M. [2 ]
Kochhar, Sonali [3 ]
Vergnano, Stefania [1 ,4 ]
Cutland, Clare L. [5 ,6 ]
Steinhoff, Mark [7 ]
Black, Steven [8 ]
Heininger, Ulrich [9 ]
Bonhoeffer, Jan [9 ]
Heath, Paul T. [1 ]
机构
[1] St Georges Univ London, Inst Infect & Immun, Paediat Infect Dis Res Grp, Jenner Wing,Level 2,Room 2-215D, London SW17 0RE, England
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Global Healthcare Consulting, Delhi, India
[4] Univ Bristol, Sch Clin Sci, Bristol BS8 1TH, Avon, England
[5] Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa
[6] Univ Witwatersrand, Fac Hlth Sci, Natl Res Fdn, Dept Sci & Technol,Vaccine Preventable Dis, ZA-2050 Johannesburg, South Africa
[7] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[8] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA
[9] Univ Basel, Childrens Hosp, Basel, Switzerland
基金
比尔及梅琳达.盖茨基金会;
关键词
Adverse event; Immunization; Pregnancy; Guidance; Clinical trials; Vaccines; Safety; Case report form; VACCINATION; INFANTS; IMMUNIZATION;
D O I
10.1016/j.vaccine.2016.07.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination in pregnancy is an effective strategy to prevent serious infections in mothers and their infants. Safety of this strategy is of principal importance to all stakeholders. As the number of studies assessing safety of vaccines in pregnancy increases, the need to ensure consistent collection and reporting of critical data to allow comparisons and data pooling becomes more important. The Global Alignment of Immunization Safety Assessment in Pregnancy (GALA) project aims to improve data collection and create a shared understanding of maternal, fetal and neonatal outcomes in order to progress the global agenda for vaccination in pregnancy. The guidance in this document has been developed to harmonize the data collected in case report forms used for safety monitoring in clinical trials of vaccination in pregnant women. Data to be collected is prioritized to allow applicability in diverse research settings, including low and middle-income countries. Standardized data will enable the research community to have a common base upon which to conduct meta-analyses, strengthening the applicability of outcomes to different settings. (C) 2016 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:6007 / 6014
页数:8
相关论文
共 14 条
[11]  
International Alliance for Biological Standardization, 2016, HARM SAF MON IMM PRE
[12]  
Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI [10.1056/NEJMoa1401480, 10.1056/NEJMc1412050]
[13]   Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? [J].
Munoz, Flor M. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (03) :221-224
[14]   Effectiveness of maternal influenza immunization in mothers and infants [J].
Zaman, K. ;
Roy, Eliza ;
Arifeen, Shams E. ;
Rahman, Mahbubur ;
Raqib, Rubhana ;
Wilson, Emily ;
Omer, Saad B. ;
Shahid, Nigar S. ;
Breiman, Robert E. ;
Steinhoff, Mark C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1555-1564